Isoflavones: estrogenic activity, biological effect and bioavailability

Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms

(2011) Silvina Levis   ARCHIVES OF INTERNAL MEDICINE

G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling

(2011) Bengt-Olof Nilsson et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of Dietary Ingredients on Function and Expression of P-Glycoprotein in Human Intestinal Epithelial Cells

(2010) Takashi Okura et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Enhanced Oral Bioavailability of Daidzein by Self-Microemulsifying Drug Delivery System

(2010) Qi Shen et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?

(2010) Sundeep Khosla et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Equol: History, Chemistry, and Formation

(2010) Kenneth D. R. Setchell et al.   JOURNAL OF NUTRITION

Effects of a High Dose, Aglycone-Rich Soy Extract on Prostate-Specific Antigen and Serum Isoflavone Concentrations in Men With Localized Prostate Cancer

(2010) Ralph W. deVere White et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Emerging role of estrogen in the control of cardiometabolic disease

(2010) Andrea Cignarella et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Conversion of Daidzein and Genistein by an Anaerobic Bacterium Newly Isolated from the Mouse Intestine

(2008) A. Matthies et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY